Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Edwin J. Whitney"'
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 15:380-383
Introduction: High-density lipoprotein (HDL) cholesterol is a well-established inverse risk factor for cardiovascular disease. The extent to which cardiovascular risk can be modified through changes in HDL, however, is less clear. We further examined
Autor:
H.Alfred Tyroler, Stephen E. Weis, Deborah R. Shapiro, William Kruyer, Polly A. Beere, Antonio M. Gotto, Edwin J. Whitney, Michael Clearfield, Alexandra Langendorfer, John R. Downs, Vladimir Zagrebelsky
Publikováno v:
The American Journal of Cardiology. 87:1074-1079
This study presents the long-term safety data from AFCAPS/TexCAPS, the first primary prevention trial to demonstrate that men and women with average levels of low-density lipoprotein cholesterol (LDL-C) and below average levels of high-density lipopr
Autor:
Charles M. Alexander, Stephen J. Boccuzzi, Gregg S. Meyer, Stephen E. Weis, Antonio M. Gotto, James B. Roehm, Michael Clearfield, Edwin J. Whitney, John R. Cook
Publikováno v:
The American Journal of Cardiology. 86:1176-1181
This cost-consequences analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study compares the costs of lovastatin treatment with the costs of cardiovascular hospitalizations and procedures. The cost of lovastatin treatment was defined
Autor:
Edwin J. Whitney
Publikováno v:
Current Atherosclerosis Reports. 1:38-43
Atherosclerotic cardiovascular diseases are the most common causes of death in the United States. Fibrous plaques develop in 77% to 78% of men before age 30. The mean low-density lipoprotein-cholesterol (LDL-C) level in men aged 25 to 30 years is 117
Autor:
Robert Kalenian, Thomas C. Andrews, Bradley E. Personius, Edwin J. Whitney, Garfield G. Green
Publikováno v:
The American Journal of Cardiology. 80:831-835
We studied endothelial function using the brachial artery ultrasound model in 100 subjects from the Armed Forces Regression Study, a placebo-controlled, angiographic regression trial in subjects with normal or modestly elevated low-density lipoprotei
Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Autor:
Alexandra Langendorfer, Stephen E. Weis, John R. Downs, Jeffrey Rochen, Edwin J. Whitney, Deborah R. Shapiro, Evan A. Stein, Polly A. Beere, Antonio M Gotto, Michael Clearfield
Publikováno v:
The American Journal of Cardiology. 80:287-293
The Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) is a randomized, double-blind, placebo-controlled primary prevention trial. It is designed to test the hypothesis that in addition to a lipid-lowering diet, treatment with
Publikováno v:
The American Journal of Cardiology. 70:738-743
Coronary artery disease (CAD) primary end point definitions used in previous prevention trials are reviewed, as well as trends over time for CAD mortality, incidence and hospital discharges to see if new primary end points should be considered. CAD m
Autor:
Santica M. Marcovina, Alan Chait, Edwin J. Whitney, John J. Albers, Blazej Neradilek, Jefferson Baer, Richard A. Krasuski, B. Greg Brown, Xue Qiao Zhao
Publikováno v:
The American journal of cardiology. 104(11)
We examined the impact of metabolic syndrome (MS) on coronary stenosis progression and major cardiovascular (CV) events and investigated the mitigating effects of low-density lipoprotein (LDL) cholesterol lowering and LDL cholesterol lowering plus hi
Publikováno v:
Military Medicine. 156:422-429
Seven patients with atherosclerotic coronary artery disease documented by coronary angiography and exercise stress testing were treated with the American Heart Association Step II Diet, a walking program, and combination drug therapy with niacin, cho
Autor:
Bradley E. Personius, Richard A. Krasuski, Antonio M. Gotto, Ara M. Maranian, B. Greg Brown, Edwin J. Whitney
Publikováno v:
Journal of the American College of Cardiology. 41(6)